On October 30, 2026, Celestica Inc. (NYSE: CLS; TSX: CLS) announced that the Toronto Stock Exchange (TSX) has accepted the Company's notice to launch a new Normal Course Issuer Bid (NCIB). The program allows Celestica to repurchase up to 3,132,127 of its common shares, representing approximately 2.5 percent of the public float as of October 20, 2026.
The repurchase period is scheduled to commence on November 3, 2026, and terminate on November 2, 2027. Under the TSX rules, daily purchases on the TSX are limited to 109,076 common shares, based on the average daily trading volume of 436,307 over the six months ended September 30, 2026, with exceptions for block purchases.
Purchases are expected to be made through the TSX, the New York Stock Exchange, other designated exchanges, or alternative trading systems at prevailing market prices. The program will be funded using existing cash resources and available credit facilities. Celestica has also entered into an automatic share purchase plan (ASPP) with a designated broker to facilitate purchases during blackout periods.
As of October 20, 2026, the Company had 126,111,808 issued and outstanding common shares, with a public float of 125,285,094 shares. The Company noted that the maximum number of shares repurchasable will be reduced by shares bought back by non-independent brokers for stock-based compensation plans.
Celestica also disclosed that its previous NCIB, which expired on November 2, 2026, authorized the purchase of up to 5,722,527 shares. Under that program, the Company repurchased and cancelled 205,184 shares at a weighted average price of US$271.75 per share through October 20, 2026.
